Jobs / United States / Abbvie INC
Director, Competitive & Strategic Insights, Oncology Lead
Abbvie INC · 🇺🇸 North Chicago, IL, US
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Abbvie INC paid sponsored hires in similar roles2 certified filings for “Intercontinental Market Access Director, Oncology” (Market Research Analysts and Marketing Specialists) in IL: $191k–$260k, median $225k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Abbvie INC
The US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Abbvie INC →
About the role
The CSI Director drives insights at a global level (with a US focus) for pre-clinical to late clinical Oncology assets, providing an objective view of the competitive landscape and emerging trends. This individual will be a strategic partner to the asset strategy teams and influence the overall development of the assets or key mechanisms of interest. Responsibilities include informing the clinical target product profile, supporting go/no go decisions, tracking safety & efficacy data of competitors, assessing evolution of the standard of care, understanding clinical timelines and competitor status. The CSI team supports key governance decisions at asset milestones and partners with BD and S&E. The individual in this role will have high visibility and opportunities to influence key decisions to support AbbVie’ Oncology pipeline. Responsibilities: • Scientific expertise for ease in informing and aligning with clinical and discovery scientists as this role will include evaluation of early development targets, trends and assets • Develop R&D CI and generate insights across key Oncology indications (including but not limited to SCLC, Neuroendocrine, HNSCC) as well as emerging MOAs (including but not limited to ADC, TCE, in vivo CAR T) • Rapidly develop functional expertise in new disease-areas and technologies as priorities shift • Drive and execute the CI plan to embed research and clinical insights across the portfolio of assets; ensure the CI plan is supported by robust methodology and delivered in a timely manner • Be an influential voice regarding R&D/BD CI within the organization; advise senior management on CI topics and implications for AbbVie • Create strategic partnerships with internal CI beneficiaries and resources (R&D leadership, TASCs, ASTs, Global Medical Affairs, Discovery Research, Development, Search & Evaluation, Business Development & Acquisitions, PCS, IMABI and APEX) • Communicate competitive intelligence in a timely and actionable manner, including implications, in a succinct manner • Advance and coordinate standard CI deliverables (conference coverage, alerts, landscapes, etc.) across the CI team; ensure consistency and create synergies across AbbVie assets by maintaining the same framework for key deliverables • Develop and maintain a repository of clinical knowledge for each area of interest that will become a reference set of documents (e.g., on SharePoint, proprietary platforms, etc.) to develop strategies • Act as a CI expert, demonstrating awareness and understanding of appropriate CI applications and key internal and external data/information sources • Bring innovative methodologies and approaches into the organization • Build and maintain required CI tools and platforms to enable process efficiency, ease of access and content management • Effectively deliver against competing priorities in time-sensitive environment • Work collaboratively across the Competitive Intelligence team, ensuring continued high-performance and collective success • Manage CI vendors, as necessary • Operate Competitive Intelligence within AbbVie SOPs and CI policy and highest standard of professional conduct • Bachelor’s Degree health/life sciences required; Advanced degree (PhD, PharmD) in Life Sciences/Medicine is preferred • 7-9 years of experience in Pharma/Biotech with 3-5+ years of experience CI or market research in Pharma/Biotech pipeline assets; Oncology clinical development/regulatory experience preferred • Expertise with broad range of CI methodologies (preferred) • Experience in US (required) and multiple regions (preferred) • Superior analytical skills are required with an understanding of R&D • Proficiency with global and regional CI vendors necessary to assess clinical status and end to end ov